$CYDY CytoDyn a biotechnology company developing innovative treatments for multiple therapeutic indications based on leronlimab, a novel humanized monoclonal antibody targeting the CCR5 receptor. #CYDY
Annual shareholders meeting update. https://www.cytodyn.com/newsroom/press-releas...meeting-of